Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/22/2007EP1819663A1 Omega-phenyloctanamides
08/22/2007EP1819366A1 A staining composition for staining an ophthalmic membrane
08/22/2007EP1819365A2 Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering rnas
08/22/2007EP1819364A2 Immunomodulatory compositions, combinations and methods
08/22/2007EP1819362A2 Topical nepafenac formulations
08/22/2007EP1819361A2 Pharmaceutical combinations
08/22/2007EP1819353A1 Composition for proteasome inhibition
08/22/2007EP1819350A2 Pharmaceutical formulations cytidine analogs and derivatives
08/22/2007EP1819349A2 Enhancing treatment of hif-1 mediated disorders with adenosine a3 receptor agonists
08/22/2007EP1819348A1 Method for treating hiv infection through co-administration of tipranavir and gw695634
08/22/2007EP1819347A1 Treating acute exacerbations of asthma using a ketolide
08/22/2007EP1819346A2 Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases
08/22/2007EP1819345A2 Use of lipid conjugates in the treatment of disease
08/22/2007EP1819344A2 Separation of fulvestrant isomers
08/22/2007EP1819343A2 A method of administering anti-angiogenic agents and a method of treating disease using same
08/22/2007EP1819342A1 Quinoline tachykinin receptor antagonists
08/22/2007EP1819341A2 Il-12 modulatory compounds
08/22/2007EP1819340A2 Methods and compositions for the treatment of pulmonary hypertension of the newborn
08/22/2007EP1819339A1 A combination of n-(3-metoxy-5-methylpyrazin-2-yl)-2-(4-`1,3,4-oxadiazol-2-ylüphenyl)pyridine-3-sulphonamide and an anti-mitotic agent for the treatment of cancer
08/22/2007EP1819338A2 Tubulin binding anti cancer agents and prodrugs thereof
08/22/2007EP1819337A2 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
08/22/2007EP1819336A2 Dose forms comprising vx-950 and their dosage regimen
08/22/2007EP1819335A1 Method for treating hiv infection through co-administration of tipranavir and sch-417690
08/22/2007EP1819334A1 Methods of treating erythropoietin-resistance
08/22/2007EP1819333A1 Method for treating hiv infection through co-administration of tipranavir and gw873140
08/22/2007EP1819332A2 Pyrrolopyridine-2-carboxylic acid amides
08/22/2007EP1819331A1 Combinations comprising epothilones and protein tyrosine kinase inhibitors and pharmaceutical uses thereof
08/22/2007EP1819330A1 5-carboxamido substitued thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family
08/22/2007EP1819329A2 Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
08/22/2007EP1819328A1 Adjunctive therapy for depression
08/22/2007EP1819327A1 Inhalation medicament containing an anticholinesterase drug, salmeterol and a steroid selected from the ciclesonide or mometasone furoate group
08/22/2007EP1819326A1 Dosage regimen of an s1p receptor agonist
08/22/2007EP1819323A2 Pharmaceutical composition containing an anti-nucleating agent
08/22/2007EP1819322A2 Formulations of substituted benzoxazoles
08/22/2007EP1819321A2 Formulations of substituted benzoxazoles
08/22/2007EP1819319A1 Pharmaceutical compositions of amorphous atorvastatin and process for preparing same
08/22/2007EP1819297A2 Uv cured gel and method of making
08/22/2007EP1819238A2 Use of diacetyl trimer as an aromatic and flavouring substance
08/22/2007EP1819227A1 Pharmaceutical formulation of decitabine
08/22/2007EP1819226A2 Immunostimulatory combinations and methods
08/22/2007EP1742903B1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
08/22/2007EP1734972A4 Method of treating solid tumors and leukemias using combination therapy of vitamin d and anti-metabolic nucleoside analogs
08/22/2007EP1720870B1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/22/2007EP1687292B1 Vitamin d receptor modulators
08/22/2007EP1684851B1 Methods for preparing polymeric buffer formulations for electrotransport applications
08/22/2007EP1648904B1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands
08/22/2007EP1615919B1 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands
08/22/2007EP1610785B1 Pharmaceutical combination for the treatment of spasticity and/or pain
08/22/2007EP1592431A4 Method of modulating il-6
08/22/2007EP1578755B1 Phosphonooxy quinazoline derivatives and their pharmaceutical use
08/22/2007EP1572670B1 5-substituted-pyrazine or -pyridine glucokinase activators
08/22/2007EP1567869B1 Method for screening for compounds as potential sedatives or anxiolytics
08/22/2007EP1567502B1 Substituted dihydrophenanthridinesul fonamides
08/22/2007EP1560809B1 Cyclohexylurea derivatives
08/22/2007EP1554246B1 Dihydropyridinone derivatives as hne inhibitors
08/22/2007EP1537122B1 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
08/22/2007EP1536806B1 Use of hesperidine or one of its derivatives for making a medicine for bone formation stimulation
08/22/2007EP1527073B1 Benzothiophene urea, benzofurane urea, and indole urea, and use of the same as alpha-7 achr agonists
08/22/2007EP1499320B1 Novel compounds
08/22/2007EP1476470B1 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments
08/22/2007EP1467970B1 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
08/22/2007EP1467728B1 Pharmaceutical compositions comprising valsartan and nep inhibitors
08/22/2007EP1453804B1 Ccr-3 receptor antagonists vii
08/22/2007EP1448523B1 Heterocyclic compounds and methods of use
08/22/2007EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
08/22/2007EP1379513B1 Prodrugs of cox-2 inhibitors
08/22/2007EP1359920B1 Uses of oral formulations for the treatment of female sexual dysfunction
08/22/2007EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
08/22/2007EP1351673B1 Compositions of stable t3 and use thereof
08/22/2007EP1335700B1 Pharmaceutical composition comprising chelating/sequestering agents and their dermatological use
08/22/2007EP1300399B1 Phenylpyridazine derivatives and drugs containing the same
08/22/2007EP1242009B1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds
08/22/2007EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS
08/22/2007EP1227804B1 Use of eplerenone for treating restenosis
08/22/2007EP1183256B1 Purine derivatives, preparation method and pharmaceutical compositions containing same
08/22/2007EP1178952B1 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
08/22/2007EP1158971B1 Gardos channel antagonists
08/22/2007EP1150980B1 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/22/2007EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/22/2007EP1136470B1 Process for the preparation of a piperazine derivative
08/22/2007EP1124824B1 Chromenone and chromanone derivatives as integrin inhibitors
08/22/2007EP1124568B1 Polyspecific binding molecules and uses thereof
08/22/2007EP1067138B1 Hydroxyproline derivatives
08/22/2007EP1052975B1 Propofol composition containing sulfite
08/22/2007EP1017846B1 Control of immune responses by modulating activity of glycosyltransferases
08/22/2007EP0933423B1 Meltrins
08/22/2007EP0925069B1 Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer
08/22/2007EP0877555B1 Use of an inhibitor of an immune system costimulation event for the preparation of a medicament inhibiting the immune system destruction of transplanted viable non-embryonic cells
08/22/2007EP0773950B1 Linked peptide nucleic acids
08/22/2007EP0715856B1 Keratin-storable antifungal composition for external use
08/22/2007CN1332983C Polysaccharide of rhizoma corydalis, preparation method and application
08/22/2007CN1332974C Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use
08/22/2007CN1332971C Luteolin-7-O-bata-glucuronide and its extracting process and application thereof
08/22/2007CN1332969C Flavonoid glycoside compound and its preparing process
08/22/2007CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion
08/22/2007CN1332960C Imidazoquinoline derivatives as adenosine A3 receptor ligands
08/22/2007CN1332959C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/22/2007CN1332954C Dipeptidyl peptidase IV effectors
08/22/2007CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
08/22/2007CN1332946C Premedicine acting on nervous centralis system
1 ... 3617 3618 3619 3620 3621 3622 3623 3624 3625 3626 3627 3628 3629 3630 3631 3632 3633 3634 3635 3636 3637 ... 7860